InvestSMART

Avecho Biotechnology Limited (ASX: AVE) - Announcements

Current share price for AVE : $0.023 0.002 (9.52%)+

ASX company news and announcements for Avecho Biotechnology Limited (AVE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Avecho Biotechnology Limited (AVE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Avecho Biotechnology Limited (AVE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Avecho Biotechnology Limited (AVE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$89 Notification of cessation of securities - AVE 10 Sep 2021 5:01PM $0.018 $0.023 risen by 27.78%
$89 Appendix 4D and Half-year Financial Report 24 Aug 2021 8:41AM $0.017 $0.023 risen by 35.29%
$89 June 2021 Quarterly Activities Report & Appendix 4C 27 Jul 2021 8:39AM $0.020 $0.023 risen by 15%
$89 Application for quotation of securities - AVE 1 Jul 2021 9:37AM $0.017 $0.023 risen by 35.29%
$89 Section 708A Cleansing Statement 1 Jul 2021 9:36AM $0.017 $0.023 risen by 35.29%
$89 Avecho to Present New CBD Data at GCI Virtual Summit 8 Jun 2021 10:10AM $0.018 $0.023 risen by 27.78%
$89 Change of Director's Interest Notice x3 31 May 2021 4:39PM $0.019 $0.023 risen by 21.05%
$89 Appendix 3G 31 May 2021 4:37PM $0.019 $0.023 risen by 21.05%
$89 Final Director's Interest Notice 31 May 2021 4:35PM $0.019 $0.023 risen by 21.05%
$89 2021 Annual General Meeting Results 31 May 2021 4:32PM $0.019 $0.023 risen by 21.05%
$89 Chair's Address and CEO Presentation 31 May 2021 12:38PM $0.018 $0.023 risen by 27.78%
$89 AB Vista to explore new TPM applications for Animal Health 31 May 2021 8:36AM $0.017 $0.023 risen by 35.29%
$89 Changes to AGM attendance protocols 26 May 2021 5:37PM $0.016 $0.023 risen by 43.75%
$89 TGA meeting for CBD soft-gel targeting insomnia 26 May 2021 9:24AM $0.015 $0.023 risen by 53.33%
$89 Avecho completes pharmaceutical CBD soft-gel product 21 May 2021 9:38AM $0.015 $0.023 risen by 53.33%
$89 Resignation of Director & Withdrawal of AGM Resolution 4 May 2021 4:44PM $0.020 $0.023 risen by 15%
$89 Notice of Annual General Meeting/Proxy Form 30 Apr 2021 2:10PM $0.020 $0.023 risen by 15%
$89 March 2021 Quarterly Activities Report & Appendix 4C 28 Apr 2021 4:10PM $0.020 $0.023 risen by 15%
$89 Avecho receives ethics approval for CBD human trial 13 Apr 2021 8:57AM $0.022 $0.023 risen by 4.55%
$89 Appendix 4G and Corporate Governance Statement 26 Mar 2021 9:55AM $0.022 $0.023 risen by 4.55%
$89 Annual Report - 31 December 2020 26 Mar 2021 9:52AM $0.022 $0.023 risen by 4.55%
$89 Appendix 4E - Preliminary Final Report 26 Feb 2021 2:56PM $0.022 $0.023 risen by 4.55%
$89 Appendix 2A - Options 17 Feb 2021 5:49PM $0.025 $0.023 fallen by 8%
$89 S708A Cleansing Notice and Appendix 2A 17 Feb 2021 5:23PM $0.025 $0.023 fallen by 8%
$89 Update - Proposed issue of Securities - AVE 16 Feb 2021 5:09PM $0.026 $0.023 fallen by 11.54%

176 - 200 of 314 results

Page 8 of 13

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.